American Trust reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 12.3% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 11,657 shares of the healthcare conglomerate's stock after selling 1,637 shares during the quarter. UnitedHealth Group makes up 1.5% of American Trust's portfolio, making the stock its 10th biggest position. American Trust's holdings in UnitedHealth Group were worth $6,105,000 as of its most recent SEC filing.
A number of other large investors also recently modified their holdings of UNH. GAMMA Investing LLC lifted its position in shares of UnitedHealth Group by 56,142.1% in the 1st quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock worth $4,344,586,000 after buying an additional 8,280,404 shares during the last quarter. Nuveen LLC bought a new stake in UnitedHealth Group in the 1st quarter valued at about $3,846,764,000. Vanguard Group Inc. grew its position in UnitedHealth Group by 6.6% in the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock worth $47,519,620,000 after purchasing an additional 5,583,343 shares during the last quarter. Wellington Management Group LLP grew its position in UnitedHealth Group by 10.6% in the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock worth $13,537,859,000 after purchasing an additional 2,486,839 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in UnitedHealth Group by 36.6% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate's stock worth $4,346,712,000 after purchasing an additional 2,301,010 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.
UnitedHealth Group Stock Up 1.6%
UNH stock opened at $320.46 on Tuesday. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The firm has a market cap of $290.24 billion, a PE ratio of 13.88, a P/E/G ratio of 2.04 and a beta of 0.45. The firm has a 50 day simple moving average of $288.96 and a 200 day simple moving average of $371.54. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same period in the prior year, the company earned $6.80 earnings per share. The firm's revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
UnitedHealth Group Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be issued a dividend of $2.21 per share. The ex-dividend date is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.8%. UnitedHealth Group's payout ratio is currently 38.30%.
Analysts Set New Price Targets
A number of brokerages have recently commented on UNH. Hsbc Global Res lowered UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a report on Wednesday, May 21st. Wolfe Research dropped their price target on shares of UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating on the stock in a research report on Tuesday, May 20th. Truist Financial dropped their price target on shares of UnitedHealth Group from $360.00 to $345.00 and set a "buy" rating on the stock in a research report on Wednesday, July 16th. Barclays boosted their price target on shares of UnitedHealth Group from $337.00 to $352.00 and gave the stock an "overweight" rating in a research report on Thursday, September 4th. Finally, Bank of America boosted their price target on shares of UnitedHealth Group from $290.00 to $325.00 and gave the stock a "neutral" rating in a research report on Monday, August 18th. Sixteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat.com, UnitedHealth Group presently has an average rating of "Moderate Buy" and an average price target of $354.86.
Read Our Latest Report on UnitedHealth Group
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.